Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
san diego blog main
4
×
san diego top stories
4
×
boston blog main
boston top stories
fda
san diego
seattle blog main
startups
abide therapeutics
accent therapeutics
acquisition
aducanumab
allergan
alzheimer's disease
amblyotech
amylin pharmaceuticals
asklepios biopharmaceutical
ben cravatt
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
boston
botox
boulder/denver blog main
boulder/denver top stories
brainvectis
bristol-myers squibb
c. greg guyer
cancer
cara therapeutics
carlsmed
clinical trials
deals
deerfield management
detroit blog main
detroit top stories
What
developing
4
×
medicines
company
ipo
therapeutics
abide
activity
appointed
approvals
based
bio
biogen
brings
carlsmed
chief
clamped
covid
delays
diego
diseases
disorders
drug
dyne
dyne’s
economic
executive
fast
fda
finney
genetic
imaging
implants
including
isn’t
kevin
lot
medical
medtech
merged
merges
Language
unset
unknown
Current search:
biotech
×
developing
×
" san diego blog main "
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President